185 related articles for article (PubMed ID: 23736149)
21. Impact of low-level viremia with drug resistance on CD4 cell counts among people living with HIV on antiretroviral treatment in China.
Liu P; You Y; Liao L; Feng Y; Shao Y; Xing H; Lan G; Li J; Ruan Y; Li D
BMC Infect Dis; 2022 May; 22(1):426. PubMed ID: 35509014
[TBL] [Abstract][Full Text] [Related]
22. Feasibility and Efficacy of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation for HIV-Associated Lymphoma: A Single-Institution Experience.
Ayala E; Chavez JC; Gomez A; Sleiman E; Kumar A; Kharfan-Dabaja MA
Clin Lymphoma Myeloma Leuk; 2018 Aug; 18(8):548-551. PubMed ID: 29937399
[TBL] [Abstract][Full Text] [Related]
23. A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy.
Bower M; Gazzard B; Mandalia S; Newsom-Davis T; Thirlwell C; Dhillon T; Young AM; Powles T; Gaya A; Nelson M; Stebbing J
Ann Intern Med; 2005 Aug; 143(4):265-73. PubMed ID: 16103470
[TBL] [Abstract][Full Text] [Related]
24. Low-Level Viremia Predicts Virological Failure in HIV-Infected Omani Patients Receiving Antiretroviral Therapy.
Gaifer Z; Boulassel MR
J Int Assoc Provid AIDS Care; 2020; 19():2325958220979817. PubMed ID: 33372823
[TBL] [Abstract][Full Text] [Related]
25. Short communication: spectrum of non-Hodgkin lymphoma in an urban Ryan White-funded clinic in the established antiretroviral era.
Silverton A; Gunthel C; Adamski M; Mosunjac M; Nguyen ML
AIDS Res Hum Retroviruses; 2014 Jul; 30(7):665-9. PubMed ID: 24707838
[TBL] [Abstract][Full Text] [Related]
26. The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.
Vilchez RA; Finch CJ; Jorgensen JL; Butel JS
Medicine (Baltimore); 2003 Mar; 82(2):77-81. PubMed ID: 12640183
[TBL] [Abstract][Full Text] [Related]
27. Incidence of lymphoma in HIV-HCV-infected patients. Modifications in function of the anti-hepatitis C virus therapy.
Gutiérrez-Saborido D; Gutiérrez-Valencia A; González Domenech CM; López Ruz MÁ; Raffo Márquez M; Omar M; Girón-González JA;
Ann Hematol; 2019 Aug; 98(8):1953-1959. PubMed ID: 31025161
[TBL] [Abstract][Full Text] [Related]
28. Copy-Years Viremia and Risk of Virological Failure in Long-Term-Treated HIV Patients.
Falasca F; De Vito C; Mazzuti L; di Carlo D; Celani L; Fimiani C; dʼEttorre G; Mezzaroma I; Antonelli G; Turriziani O
J Acquir Immune Defic Syndr; 2019 Apr; 80(4):423-428. PubMed ID: 30531307
[TBL] [Abstract][Full Text] [Related]
29. The effect of a "universal antiretroviral therapy" recommendation on HIV RNA levels among HIV-infected patients entering care with a CD4 count greater than 500/μL in a public health setting.
Geng EH; Hare CB; Kahn JO; Jain V; Van Nunnery T; Christopoulos KA; Deeks SG; Gandhi M; Havlir DV
Clin Infect Dis; 2012 Dec; 55(12):1690-7. PubMed ID: 22955429
[TBL] [Abstract][Full Text] [Related]
30. Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma.
Barta SK; Lee JY; Kaplan LD; Noy A; Sparano JA
Cancer; 2012 Aug; 118(16):3977-83. PubMed ID: 22180164
[TBL] [Abstract][Full Text] [Related]
31. Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent antiretroviral therapies.
Wohl DA; Zeng D; Stewart P; Glomb N; Alcorn T; Jones S; Handy J; Fiscus S; Weinberg A; Gowda D; van der Horst C
J Acquir Immune Defic Syndr; 2005 Apr; 38(5):538-44. PubMed ID: 15793363
[TBL] [Abstract][Full Text] [Related]
32. Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy era.
Engels EA; Pfeiffer RM; Landgren O; Moore RD
J Acquir Immune Defic Syndr; 2010 May; 54(1):78-84. PubMed ID: 20418723
[TBL] [Abstract][Full Text] [Related]
33. Influence of lifelong cumulative HIV viremia on long-term recovery of CD4+ cell count and CD4+/CD8+ ratio among patients on combination antiretroviral therapy.
Seng R; Goujard C; Krastinova E; Miailhes P; Orr S; Molina JM; Saada M; Piroth L; Rouzioux C; Meyer L;
AIDS; 2015 Mar; 29(5):595-607. PubMed ID: 25715104
[TBL] [Abstract][Full Text] [Related]
34. Effect of persistent moderate viremia on disease progression during HIV therapy.
Raffanti SP; Fusco JS; Sherrill BH; Hansen NI; Justice AC; D'Aquila R; Mangialardi WJ; Fusco GP;
J Acquir Immune Defic Syndr; 2004 Sep; 37(1):1147-54. PubMed ID: 15319674
[TBL] [Abstract][Full Text] [Related]
35. ART in HIV-Positive Persons With Low Pretreatment Viremia: Results From the START Trial.
Sereti I; Gulick RM; Krishnan S; Migueles SA; Palfreeman A; Touzeau-Römer V; Belloso WH; Emery S; Law MG;
J Acquir Immune Defic Syndr; 2019 Aug; 81(4):456-462. PubMed ID: 31241541
[TBL] [Abstract][Full Text] [Related]
36. Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women.
Kourtis AP; Wiener J; King CC; Heffron R; Mugo NR; Nanda K; Pyra M; Donnell D; Celum C; Lingappa JR; Baeten JM;
J Acquir Immune Defic Syndr; 2017 Jan; 74(1):38-43. PubMed ID: 27787340
[TBL] [Abstract][Full Text] [Related]
37. Trajectory analyses of virologic outcomes reflecting community-based HIV treatment in Washington DC 1994-2012.
Ocampo JM; Plankey M; Zou K; Collmann J; Wang C; Young MA; Liu C; Ripple JA; Kassaye S
BMC Public Health; 2015 Dec; 15():1277. PubMed ID: 26695971
[TBL] [Abstract][Full Text] [Related]
38. Virological Outcome After Choice of Antiretroviral Regimen Guided by Proviral HIV-1 DNA Genotyping in a Real-Life Cohort of HIV-Infected Patients.
Meybeck A; Alidjinou EK; Huleux T; Boucher A; Tetart M; Choisy P; Bocket L; Ajana F; Robineau O
AIDS Patient Care STDS; 2020 Feb; 34(2):51-58. PubMed ID: 32049556
[TBL] [Abstract][Full Text] [Related]
39. Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.
Lodi S; Phillips A; Logan R; Olson A; Costagliola D; Abgrall S; van Sighem A; Reiss P; Miró JM; Ferrer E; Justice A; Gandhi N; Bucher HC; Furrer H; Moreno S; Monge S; Touloumi G; Pantazis N; Sterne J; Young JG; Meyer L; Seng R; Dabis F; Vandehende MA; Pérez-Hoyos S; Jarrín I; Jose S; Sabin C; Hernán MA;
Lancet HIV; 2015 Aug; 2(8):e335-43. PubMed ID: 26423376
[TBL] [Abstract][Full Text] [Related]
40. All-Cause Mortality and Serious Non-AIDS Events in Adults With Low-level Human Immunodeficiency Virus Viremia During Combination Antiretroviral Therapy: Results From a Swedish Nationwide Observational Study.
Elvstam O; Marrone G; Medstrand P; Treutiger CJ; Sönnerborg A; Gisslén M; Björkman P
Clin Infect Dis; 2021 Jun; 72(12):2079-2086. PubMed ID: 32271361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]